ArticleiScience2022

Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern.

Hadas Cohen-Dvashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.